Skip to Main Content

++

Abbreviations

++
Table Graphic Jump Location
Favorite Table | Download (.pdf) | Print

AED

Antiepileptic drug

CBZ

Carbamazepine

CNS

Central nervous system

COMT

Catechol-O-methyltransferase

DHE

Dihydroergotamine

FBM

Felbamate

GTC

Generalized tonic–clonic

JME

Juvenile myoclonic epilepsy

LAC

Lacosamide

LEV

Levetiracetam

LMWH

Low molecular-weight heparin

LOC

Loss of consciousness

LTG

Lamotrigine

LV

Left ventricle

MAO

Monoamine oxidase

MAOI

Monoamine oxidase inhibitor

NSAID

Nonsteroidal anti-inflammatory drug

PB

Phenobarbital

PFO

Patent foramen ovale

PHT

Phenytoin

PRM

Primidone

RUF

Rufinamide

t-PA

Alteplase (tissue plasminogen activator)

TCA

Tricyclic antidepressant

TGB

Tiagabine

TPM

Topiramate

VPA

Valproic acid

VTE

Venous thromboembolism

XR

Extended release

ZON

Zonisamide

++
Table Graphic Jump Location
Table 4.1.1 Criteria for t-PA Use in Acute Ischemic Stroke
++
Figure 4.1.2 Pharmacotherapy of Acute Ischemic Strokea
Graphic Jump Location

Sources: (1) Furie KL, Kasner SE, Adams RJ, et al.; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227–276. (2) Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.